Concepts (190)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Methicillin-Resistant Staphylococcus aureus | 28 | 2023 | 115 | 12.400 |
Why?
|
| Staphylococcal Infections | 29 | 2023 | 151 | 11.430 |
Why?
|
| Cross Infection | 28 | 2023 | 275 | 8.300 |
Why?
|
| Community-Acquired Infections | 13 | 2022 | 68 | 3.410 |
Why?
|
| Bacteremia | 12 | 2019 | 97 | 3.260 |
Why?
|
| Infection Control | 14 | 2023 | 163 | 3.250 |
Why?
|
| Genomics | 7 | 2022 | 53 | 1.770 |
Why?
|
| Chlorhexidine | 6 | 2021 | 56 | 1.740 |
Why?
|
| Staphylococcus aureus | 8 | 2023 | 63 | 1.560 |
Why?
|
| Sexual and Gender Minorities | 2 | 2021 | 22 | 1.410 |
Why?
|
| Humans | 49 | 2023 | 26017 | 1.130 |
Why?
|
| HIV Infections | 4 | 2013 | 459 | 1.120 |
Why?
|
| Catheterization, Central Venous | 3 | 2012 | 34 | 1.060 |
Why?
|
| Staphylococcal Skin Infections | 4 | 2011 | 9 | 1.040 |
Why?
|
| Phenotype | 5 | 2021 | 290 | 1.030 |
Why?
|
| Methicillin Resistance | 4 | 2012 | 23 | 0.990 |
Why?
|
| Anti-Infective Agents, Local | 4 | 2019 | 45 | 0.970 |
Why?
|
| Skin | 3 | 2014 | 103 | 0.910 |
Why?
|
| Carrier State | 4 | 2013 | 48 | 0.900 |
Why?
|
| Nasal Cavity | 2 | 2014 | 32 | 0.790 |
Why?
|
| Hospitals | 9 | 2023 | 148 | 0.760 |
Why?
|
| Soft Tissue Infections | 4 | 2011 | 22 | 0.760 |
Why?
|
| Skin Care | 2 | 2012 | 12 | 0.760 |
Why?
|
| Baths | 2 | 2012 | 24 | 0.740 |
Why?
|
| Catheter-Related Infections | 4 | 2019 | 20 | 0.700 |
Why?
|
| Critical Care | 2 | 2014 | 190 | 0.700 |
Why?
|
| Hospital Administration | 6 | 2019 | 24 | 0.630 |
Why?
|
| Risk Factors | 9 | 2020 | 2242 | 0.620 |
Why?
|
| Disease Outbreaks | 4 | 2023 | 77 | 0.610 |
Why?
|
| United States | 13 | 2023 | 1979 | 0.550 |
Why?
|
| Male | 15 | 2021 | 14005 | 0.540 |
Why?
|
| Anti-Bacterial Agents | 4 | 2021 | 338 | 0.530 |
Why?
|
| Intensive Care Units | 6 | 2021 | 279 | 0.520 |
Why?
|
| Bacterial Load | 2 | 2013 | 12 | 0.520 |
Why?
|
| Pneumonia, Staphylococcal | 2 | 2014 | 9 | 0.500 |
Why?
|
| Gram-Positive Bacteria | 2 | 2012 | 12 | 0.490 |
Why?
|
| Nose | 2 | 2013 | 36 | 0.490 |
Why?
|
| Virulence Factors | 1 | 2014 | 9 | 0.480 |
Why?
|
| Bacterial Toxins | 1 | 2014 | 14 | 0.480 |
Why?
|
| Chicago | 6 | 2020 | 844 | 0.470 |
Why?
|
| Pharynx | 1 | 2014 | 12 | 0.470 |
Why?
|
| Quality Improvement | 3 | 2019 | 150 | 0.450 |
Why?
|
| Illinois | 3 | 2021 | 228 | 0.440 |
Why?
|
| Prisons | 1 | 2013 | 8 | 0.420 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 4 | 2015 | 31 | 0.420 |
Why?
|
| Female | 13 | 2020 | 14395 | 0.410 |
Why?
|
| HIV | 1 | 2012 | 37 | 0.390 |
Why?
|
| Inservice Training | 3 | 2019 | 26 | 0.380 |
Why?
|
| Equipment Contamination | 3 | 2019 | 23 | 0.370 |
Why?
|
| Disinfectants | 1 | 2010 | 7 | 0.360 |
Why?
|
| Homosexuality, Male | 2 | 2021 | 21 | 0.360 |
Why?
|
| Medical Staff, Hospital | 1 | 2010 | 18 | 0.350 |
Why?
|
| Prevalence | 3 | 2020 | 433 | 0.340 |
Why?
|
| Teaching Materials | 2 | 2019 | 7 | 0.340 |
Why?
|
| Disease Reservoirs | 1 | 2009 | 8 | 0.340 |
Why?
|
| Health Personnel | 2 | 2021 | 98 | 0.320 |
Why?
|
| Patient Safety | 2 | 2019 | 51 | 0.320 |
Why?
|
| Adult | 11 | 2021 | 7362 | 0.320 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 4 | 2019 | 43 | 0.320 |
Why?
|
| Molecular Epidemiology | 2 | 2021 | 25 | 0.320 |
Why?
|
| Phylogeny | 2 | 2021 | 46 | 0.320 |
Why?
|
| Emergency Service, Hospital | 1 | 2010 | 228 | 0.290 |
Why?
|
| Middle Aged | 10 | 2019 | 8505 | 0.290 |
Why?
|
| Delivery of Health Care | 3 | 2023 | 145 | 0.280 |
Why?
|
| Prospective Studies | 4 | 2019 | 1658 | 0.280 |
Why?
|
| Genome, Bacterial | 2 | 2017 | 13 | 0.270 |
Why?
|
| Sequence Analysis, DNA | 2 | 2017 | 50 | 0.270 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2021 | 73 | 0.260 |
Why?
|
| DNA, Bacterial | 2 | 2017 | 39 | 0.260 |
Why?
|
| Hand Disinfection | 3 | 2019 | 24 | 0.250 |
Why?
|
| Arizona | 1 | 2023 | 5 | 0.220 |
Why?
|
| Technology | 1 | 2023 | 5 | 0.220 |
Why?
|
| Health Facilities | 1 | 2023 | 19 | 0.220 |
Why?
|
| Poisson Distribution | 2 | 2015 | 22 | 0.210 |
Why?
|
| Personal Protective Equipment | 2 | 2019 | 11 | 0.210 |
Why?
|
| Incidence | 6 | 2011 | 713 | 0.210 |
Why?
|
| Communicable Diseases | 2 | 2023 | 22 | 0.210 |
Why?
|
| Health Care Surveys | 2 | 2019 | 61 | 0.210 |
Why?
|
| Aged | 7 | 2019 | 8703 | 0.210 |
Why?
|
| Program Development | 2 | 2019 | 61 | 0.210 |
Why?
|
| Methicillin | 1 | 2021 | 6 | 0.190 |
Why?
|
| Molecular Typing | 1 | 2021 | 8 | 0.190 |
Why?
|
| Community Networks | 1 | 2021 | 7 | 0.190 |
Why?
|
| Mupirocin | 1 | 2021 | 17 | 0.190 |
Why?
|
| Multivariate Analysis | 2 | 2013 | 295 | 0.180 |
Why?
|
| Antimicrobial Stewardship | 2 | 2019 | 9 | 0.170 |
Why?
|
| Enterocolitis, Pseudomembranous | 2 | 2010 | 11 | 0.170 |
Why?
|
| Central Venous Catheters | 1 | 2019 | 1 | 0.170 |
Why?
|
| Stakeholder Participation | 1 | 2019 | 8 | 0.170 |
Why?
|
| Formative Feedback | 1 | 2019 | 3 | 0.170 |
Why?
|
| Disinfection | 1 | 2019 | 10 | 0.170 |
Why?
|
| Organizational Objectives | 1 | 2019 | 17 | 0.170 |
Why?
|
| Patient Isolation | 1 | 2019 | 20 | 0.170 |
Why?
|
| Clostridium Infections | 3 | 2019 | 20 | 0.170 |
Why?
|
| Protective Clothing | 1 | 2019 | 9 | 0.160 |
Why?
|
| Academic Medical Centers | 2 | 2010 | 126 | 0.160 |
Why?
|
| Medical Errors | 1 | 2019 | 25 | 0.160 |
Why?
|
| Research Personnel | 1 | 2018 | 19 | 0.150 |
Why?
|
| Curriculum | 1 | 2019 | 142 | 0.150 |
Why?
|
| Environmental Microbiology | 1 | 2017 | 5 | 0.150 |
Why?
|
| Biomedical Research | 1 | 2018 | 60 | 0.150 |
Why?
|
| Bacteriological Techniques | 1 | 2017 | 17 | 0.150 |
Why?
|
| Specimen Handling | 1 | 2017 | 40 | 0.140 |
Why?
|
| Bacteria | 1 | 2017 | 74 | 0.140 |
Why?
|
| Risk Assessment | 1 | 2019 | 622 | 0.140 |
Why?
|
| Physicians | 1 | 2018 | 108 | 0.140 |
Why?
|
| Retrospective Studies | 3 | 2017 | 3294 | 0.130 |
Why?
|
| Health Services Research | 1 | 2016 | 39 | 0.130 |
Why?
|
| Hospitals, Public | 1 | 2015 | 25 | 0.130 |
Why?
|
| Urban Health Services | 1 | 2015 | 12 | 0.130 |
Why?
|
| Hospitals, Urban | 1 | 2015 | 32 | 0.130 |
Why?
|
| Culture Media | 2 | 2017 | 27 | 0.120 |
Why?
|
| Renal Dialysis | 1 | 2015 | 107 | 0.120 |
Why?
|
| Substance-Related Disorders | 1 | 2015 | 77 | 0.120 |
Why?
|
| Genetic Markers | 1 | 2014 | 34 | 0.120 |
Why?
|
| Membrane Transport Proteins | 1 | 2014 | 53 | 0.110 |
Why?
|
| Bacterial Proteins | 1 | 2014 | 67 | 0.110 |
Why?
|
| Databases, Factual | 1 | 2015 | 324 | 0.110 |
Why?
|
| Comorbidity | 1 | 2015 | 465 | 0.110 |
Why?
|
| International Classification of Diseases | 2 | 2011 | 12 | 0.110 |
Why?
|
| Immunocompromised Host | 1 | 2013 | 43 | 0.110 |
Why?
|
| Treatment Outcome | 3 | 2010 | 3292 | 0.100 |
Why?
|
| Population Surveillance | 2 | 2010 | 101 | 0.100 |
Why?
|
| Models, Statistical | 1 | 2012 | 122 | 0.100 |
Why?
|
| Regression Analysis | 1 | 2012 | 252 | 0.090 |
Why?
|
| Clinical Coding | 1 | 2011 | 4 | 0.090 |
Why?
|
| Genotype | 1 | 2012 | 335 | 0.090 |
Why?
|
| Bacteriuria | 1 | 2010 | 4 | 0.090 |
Why?
|
| Military Personnel | 1 | 2010 | 28 | 0.090 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2010 | 8 | 0.090 |
Why?
|
| Soaps | 1 | 2010 | 8 | 0.090 |
Why?
|
| Geography | 1 | 2010 | 18 | 0.090 |
Why?
|
| Cluster Analysis | 1 | 2010 | 38 | 0.090 |
Why?
|
| Blood | 1 | 2009 | 17 | 0.080 |
Why?
|
| Gram-Negative Bacteria | 1 | 2009 | 28 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2012 | 1822 | 0.080 |
Why?
|
| Sentinel Surveillance | 1 | 2009 | 6 | 0.080 |
Why?
|
| Patient Compliance | 1 | 2010 | 145 | 0.080 |
Why?
|
| Disease Susceptibility | 1 | 2009 | 66 | 0.080 |
Why?
|
| Prognosis | 2 | 2010 | 750 | 0.080 |
Why?
|
| Data Collection | 1 | 2009 | 91 | 0.080 |
Why?
|
| Drug Administration Routes | 1 | 2008 | 8 | 0.080 |
Why?
|
| Time Factors | 1 | 2012 | 1365 | 0.080 |
Why?
|
| Hygiene | 1 | 2008 | 12 | 0.080 |
Why?
|
| Drainage | 1 | 2008 | 46 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 457 | 0.060 |
Why?
|
| Young Adult | 3 | 2019 | 1852 | 0.060 |
Why?
|
| Quarantine | 1 | 2023 | 2 | 0.060 |
Why?
|
| Communicable Disease Control | 1 | 2023 | 14 | 0.060 |
Why?
|
| Pandemics | 1 | 2023 | 238 | 0.050 |
Why?
|
| Competency-Based Education | 1 | 2019 | 15 | 0.040 |
Why?
|
| Child | 1 | 2023 | 1228 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2019 | 55 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2011 | 550 | 0.040 |
Why?
|
| Gloves, Protective | 1 | 2019 | 14 | 0.040 |
Why?
|
| Patient Discharge | 2 | 2010 | 146 | 0.040 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 62 | 0.040 |
Why?
|
| Training Support | 1 | 2018 | 6 | 0.040 |
Why?
|
| Family | 1 | 2019 | 93 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 2019 | 140 | 0.040 |
Why?
|
| Career Choice | 1 | 2018 | 29 | 0.040 |
Why?
|
| Mentors | 1 | 2018 | 42 | 0.040 |
Why?
|
| Universal Precautions | 1 | 2018 | 2 | 0.040 |
Why?
|
| Vancomycin-Resistant Enterococci | 1 | 2018 | 5 | 0.040 |
Why?
|
| Health Policy | 1 | 2018 | 49 | 0.040 |
Why?
|
| Societies, Scientific | 1 | 2018 | 9 | 0.040 |
Why?
|
| Epidemiologists | 1 | 2017 | 1 | 0.040 |
Why?
|
| Resource Allocation | 1 | 2017 | 4 | 0.040 |
Why?
|
| Public Health Practice | 1 | 2017 | 7 | 0.040 |
Why?
|
| Public Health Administration | 1 | 2017 | 9 | 0.040 |
Why?
|
| Enterobacteriaceae | 1 | 2018 | 33 | 0.040 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2018 | 39 | 0.040 |
Why?
|
| Interprofessional Relations | 1 | 2017 | 34 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2018 | 146 | 0.040 |
Why?
|
| Epidemiologic Methods | 1 | 2016 | 16 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2016 | 23 | 0.030 |
Why?
|
| Unnecessary Procedures | 1 | 2016 | 26 | 0.030 |
Why?
|
| Adolescent | 2 | 2011 | 2064 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 291 | 0.030 |
Why?
|
| Virulence | 1 | 2011 | 10 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2011 | 4658 | 0.020 |
Why?
|
| Utah | 1 | 2011 | 1 | 0.020 |
Why?
|
| Baltimore | 1 | 2011 | 10 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 2011 | 31 | 0.020 |
Why?
|
| Pulmonary Embolism | 1 | 2011 | 60 | 0.020 |
Why?
|
| Biological Assay | 1 | 2010 | 6 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 485 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2009 | 26 | 0.020 |
Why?
|
| Linear Models | 1 | 2010 | 240 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2011 | 415 | 0.020 |
Why?
|